Clinical Trials Directory

Trials / Completed

CompletedNCT04905290

Conduction System Pacing Optimized Therapy

Conduction System Pacing Optimized Therapy Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the CSPOT study is to determine the best mode of cardiac resynchronization therapy (CRT) pacing for different populations of CRT patients, comparing traditional biventricular or left ventricular pacing (BiV), conduction system pacing (CSP)-only, and conduction system pacing optimized therapy (CSPOT) also known as a combination of conduction system pacing (CSP) and left ventricular (LV) pacing. Additionally, safety of the system will be assessed.

Conditions

Interventions

TypeNameDescription
DEVICELeft ventricular coronary sinus (BiV) configurationFor subjects with a pacemaker, pacing of the left ventricular coronary sinus only. For subjects with a defibrillator, biventricular pacing of the left ventricular coronary sinus and the right ventricle. During the acute protocol, the five AV delays for this intervention include the default AV delay setting, default + 30 milliseconds (ms) AV delay, default + 60 ms AV delay, default - 30ms AV delay, default - 60ms AV delay. Patients with a defibrillator will receive two additional delays LV precedes default by 30ms and LV precedes default by 60ms.
DEVICEConduction system pacing-only configurationConduction System Pacing (CSP) of the left bundle branch. During the acute protocol, the five AV delays for this intervention include the default AV delay setting, default + 30 milliseconds (ms) AV delay, default + 60 ms AV delay, default - 30ms AV delay, and default - 60ms AV delay.
DEVICEConduction System Pacing Optimized Therapy (CSPOT) configurationA combination of Left Ventricle pacing and Conduction System Pacing of the left bundle branch. During the acute protocol, the eight delays for this intervention include the default AV delay setting, default + 30 milliseconds (ms) AV delay, default + 60 ms AV delay, default - 30ms AV delay, default - 60ms AV delay, CSP precedes default by 30ms, LV precedes default by 30ms and LV precedes default by 60ms.

Timeline

Start date
2021-11-27
Primary completion
2023-04-18
Completion
2023-11-02
First posted
2021-05-27
Last updated
2025-04-15
Results posted
2025-01-17

Locations

12 sites across 4 countries: United States, Ireland, Poland, United Kingdom

Regulatory

Source: ClinicalTrials.gov record NCT04905290. Inclusion in this directory is not an endorsement.